Free Access
Issue |
Med Sci (Paris)
Volume 33, Novembre 2017
Les Cahiers de Myologie
|
|
---|---|---|
Page(s) | 34 - 38 | |
Section | Mise au point | |
DOI | https://doi.org/10.1051/medsci/201733s107 | |
Published online | 15 November 2017 |
- Protocole National de Diagnostic et de Soins (PNDS). Myasthénie autoimmune. Centre de références de pathologie neuromusculaire Paris Est, juillet 2015. [Google Scholar]
- Sanders DB, Andrews I, Howard JF, Massey JM. Seronegative myasthenia gravis. Neurology 1997 ; 48 : S40–S45. [CrossRef] [Google Scholar]
- Cordts I, Bodart N, Hartmann K, et al. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis. J Neurol 2017 ; 264 : 1193–1203. [CrossRef] [PubMed] [Google Scholar]
- Garg N, Yiannikas C, Hardy TA, et al. Late presentations of congenital myasthenic syndromes: how many do we miss?. Muscle Nerve 2016 ; 54 : 721–727. [CrossRef] [PubMed] [Google Scholar]
- Lindstrom JM, Seybold ME, Lennon VA, et al. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976 ; 26 : 1054–1059. [CrossRef] [PubMed] [Google Scholar]
- Burges J, Vincent A, Molenaar PC, et al. Passive transfer of seronegative myasthenia gravis to mice. Muscle Nerve 1994 ; 17 : 1393–1400. [CrossRef] [PubMed] [Google Scholar]
- Leite MI, Jacob S, Viegas S, et al. IgG1 antibodies to acetylcholine receptors in , seronegative‘ myasthenia gravis. Brain 2008 ; 131 : 1940–1952. [CrossRef] [PubMed] [Google Scholar]
- Devic P, Petiot P, Simonet T, et al. Antibodies to clustered acetylcholine receptor: expanding the phenotype. Eur J Neurol 2014 ; 21 : 130–134. [CrossRef] [PubMed] [Google Scholar]
- Rodríguez Cruz PM, Al-Hajjar M, et al. Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis. JAMA Neurol 2015 ; 72 : 642–649. [CrossRef] [PubMed] [Google Scholar]
- Blaes F, Beeson D, Plested P, et al. IgG from seronegative myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor. Ann Neurol 2000 ; 47 : 504–510. [CrossRef] [PubMed] [Google Scholar]
- Huda S, Waters P, Woodhall M, et al. IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG. Neurol Neuroimmunol Neuroinflamm 2017 ; 4 : e357. [CrossRef] [PubMed] [Google Scholar]
- Guptill JT, Sanders DB, Evoli A. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve 2011 ; 44 : 36–40. [CrossRef] [PubMed] [Google Scholar]
- Higuchi O, Hamuro J, Motomura M, Yamanashi Y. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 2011 ; 69 : 418–422. [CrossRef] [PubMed] [Google Scholar]
- Shen C, Lu Y, Zhang B, et al. Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. J Clin Invest 2013 ; 123 : 5190–5202. [CrossRef] [PubMed] [Google Scholar]
- Marino M, Scuderi F, Samengo D, et al. Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with myasthenia gravis. PLoS One 2015 ; 10 : e0135378. [CrossRef] [PubMed] [Google Scholar]
- Zhang B, Shen C, Bealmear B, et al. Autoantibodies to agrin in myasthenia gravis patients. PLoS One 2014 ; 9 : e91816. [CrossRef] [PubMed] [Google Scholar]
- Gasperi C, Melms A, Schoser B, et al. Anti-agrin autoantibodies in myasthenia gravis. Neurology 2014 ; 82 : 1976–1983. [CrossRef] [PubMed] [Google Scholar]
- Gallardo E, Martínez-Hernández E, Titulaer MJ, et al. Cortactin autoantibodies in myasthenia gravis. Autoimmun Rev 2014 ; 13 : 1003–1007. [CrossRef] [PubMed] [Google Scholar]
- Zoltowska KM, Belaya K, Leite M, et al. Collagen Q: a potential target for autoantibodies in myasthenia gravis. J Neurol Sci 2015 ; 348 : 241–244. [CrossRef] [PubMed] [Google Scholar]
- Szczudlik P, Szyluk B, Lipowska M, et al. Antititin antibody in early- and late-onset myasthenia gravis. Acta Neurol Scand 2014 ; 130 : 229–233. [CrossRef] [PubMed] [Google Scholar]
- Stergiou C, Lazaridis K, Zouvelou V, et al. Titin antibodies in seronegative myasthenia gravis: a new role for an old antigen. J Neuroimmunol 2016 ; 292 : 108–115. [CrossRef] [PubMed] [Google Scholar]
- Huda S, Woodhall MR, Vincent A, Heckmann JM. Characteristics of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort. Muscle Nerve 2016 ; 54 : 1023–1029. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.